Immunogenicity and effectiveness of COVID-19 booster vaccination among people living with HIV: a systematic review and meta-analysis
MQ Cheng, R Li, ZY Weng, G Song - Frontiers in Medicine, 2023 - frontiersin.org
Background The effect of booster vaccinations with the coronavirus virus disease (COVID-
19) vaccine on people living with HIV (PLWH) remains unknown. In this study, we aimed to …
19) vaccine on people living with HIV (PLWH) remains unknown. In this study, we aimed to …
SARS-CoV-2 infection is associated with uncontrolled HIV viral load in non-hospitalized HIV-infected patients from Gugulethu, South Africa
H Lambarey, MJ Blumenthal, A Chetram, W Joyimbana… - Viruses, 2022 - mdpi.com
In South Africa, high exposure to SARS-CoV-2 occurs primarily in densely populated, low-
income communities, which are additionally burdened by highly prevalent Human …
income communities, which are additionally burdened by highly prevalent Human …
[HTML][HTML] SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual
The milder clinical manifestations of Omicron infection relative to pre-Omicron SARS CoV-2
raises the possibility that extensive evolution results in reduced pathogenicity. To test this …
raises the possibility that extensive evolution results in reduced pathogenicity. To test this …
SARS-CoV-2 and HIV-1: Should HIV-1-infected individuals in sub-saharan Africa Be considered a priority group for the COVID-19 vaccines?
WL Mandala, MKP Liu - Frontiers in Immunology, 2021 - frontiersin.org
Since its emergence in 2019 SARS-CoV-2 has proven to have a higher level of morbidity
and mortality compared to the other prevailing coronaviruses. Although initially most African …
and mortality compared to the other prevailing coronaviruses. Although initially most African …
[HTML][HTML] Clinical outcomes and immunological response to SARS-CoV-2 infection among people living with HIV
EA Amegashie, P Asamoah, LEA Ativi… - … Biology and Medicine, 2024 - ncbi.nlm.nih.gov
People living with HIV (PLWH) usually suffer from co-infections and co-morbidities including
respiratory tract infections. SARS-CoV-2 has been reported to cause respiratory infections …
respiratory tract infections. SARS-CoV-2 has been reported to cause respiratory infections …
[PDF][PDF] HIV viremia is associated with compromised SARS-CoV-2 Beta variant neutralization
SH Hwa, J Snyman, M Bernstein, Y Ganga… - The Journal of …, 2022 - pure.mpg.de
SARS-CoV-2 infection may be associated with worse clinical outcomes in people with HIV
(PWH). We 3 report anti-SARS-CoV-2 antibody responses in COVID-19 hospitalized …
(PWH). We 3 report anti-SARS-CoV-2 antibody responses in COVID-19 hospitalized …
Model selection and identifiability analysis of HIV and SARS-CoV-2 co-infection model with drug therapy
Y Zhao, H Wu, H Cheng, J Lou - Communications in Nonlinear Science and …, 2023 - Elsevier
Since the immune function of AIDS patients infected with SARS-CoV-2 is impaired, it is
easier for SARS-CoV-2 to reproduce, replicate, and even mutate in the host. Therefore, the …
easier for SARS-CoV-2 to reproduce, replicate, and even mutate in the host. Therefore, the …
COVID-19 imported cases and severity: expected information from genomic characterization of SARS-CoV-2 strains in Mozambique
J Sumbana, A Passanduca, S Rubino - The Journal of Infection in …, 2021 - jidc.org
Introduction: The novel coronavirus, severe acute respiratory syndrome coronavirus-2
(SARS-CoV-2), etiological agent of coronavirus disease 2019 (COVID-19) was first reported …
(SARS-CoV-2), etiological agent of coronavirus disease 2019 (COVID-19) was first reported …
Safety and immunogenicity of booster vaccination and fractional dosing with Ad26. COV2. S or BNT162b2 in Ad26. COV2. S-vaccinated participants
We report the safety and immunogenicity of fractional and full dose Ad26. COV2. S and
BNT162b2 in an open label phase 2 trial of participants previously vaccinated with a single …
BNT162b2 in an open label phase 2 trial of participants previously vaccinated with a single …
COVID-19 severity and in-hospital mortality in an area with high HIV prevalence
MT Boswell, T Maimela, D Hameiri-Bowen… - … African Journal of HIV …, 2023 - journals.co.za
Background HIV infection causes immune dysregulation affecting T-cell and monocyte
function, which may alter coronavirus disease 2019 (COVID-19) pathophysiology …
function, which may alter coronavirus disease 2019 (COVID-19) pathophysiology …